ES2188260T3 - 3-tetrahidropiridin-4-il-indoles para el tratamiento de trastornos pscoticos. - Google Patents

3-tetrahidropiridin-4-il-indoles para el tratamiento de trastornos pscoticos.

Info

Publication number
ES2188260T3
ES2188260T3 ES99952604T ES99952604T ES2188260T3 ES 2188260 T3 ES2188260 T3 ES 2188260T3 ES 99952604 T ES99952604 T ES 99952604T ES 99952604 T ES99952604 T ES 99952604T ES 2188260 T3 ES2188260 T3 ES 2188260T3
Authority
ES
Spain
Prior art keywords
tetrahydropiridin
indoles
treatment
psychotic disorders
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99952604T
Other languages
English (en)
Inventor
Martinus T M Tulp
Der Heijden Johannes A M Van
Vliet Bernard Van
Jacobus Tipker
Hes Roelof Van
Cornelis G Kruse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duphar International Research BV
Original Assignee
Duphar International Research BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar International Research BV filed Critical Duphar International Research BV
Application granted granted Critical
Publication of ES2188260T3 publication Critical patent/ES2188260T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Un compuesto de la fórmula (I) **(Fórmula)** en donde: -R1 es halógeno, CF3, alquilo (1-3C), alcoxilo (1-3), CN o SCH3 -m toma el valor 0, 1 o 2 -R2 es H o alquilo (1-3C) -n toma el valor 3, 4, 5 o 6 -R3 es halógeno, alquilo (1-4C) o alcoxilo(1-4C) -p toma el valor 0, 1, ó 2 y sus sales de adición de ácido farmacológicamente aceptables.
ES99952604T 1998-10-16 1999-10-15 3-tetrahidropiridin-4-il-indoles para el tratamiento de trastornos pscoticos. Expired - Lifetime ES2188260T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98203499 1998-10-16

Publications (1)

Publication Number Publication Date
ES2188260T3 true ES2188260T3 (es) 2003-06-16

Family

ID=8234230

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99952604T Expired - Lifetime ES2188260T3 (es) 1998-10-16 1999-10-15 3-tetrahidropiridin-4-il-indoles para el tratamiento de trastornos pscoticos.

Country Status (29)

Country Link
US (1) US6391896B1 (es)
EP (1) EP1121356B1 (es)
JP (1) JP4659984B2 (es)
KR (1) KR100619464B1 (es)
CN (1) CN1140524C (es)
AR (1) AR020773A1 (es)
AT (1) ATE230741T1 (es)
AU (1) AU750811B2 (es)
BR (1) BR9914582A (es)
CA (1) CA2346896C (es)
CZ (1) CZ20011353A3 (es)
DE (1) DE69904849T2 (es)
DK (1) DK1121356T3 (es)
DZ (1) DZ2917A1 (es)
ES (1) ES2188260T3 (es)
HK (1) HK1039333A1 (es)
HU (1) HUP0104701A3 (es)
IL (2) IL142589A0 (es)
NO (1) NO320531B1 (es)
NZ (1) NZ511289A (es)
PL (1) PL195734B1 (es)
RU (1) RU2222535C2 (es)
SI (1) SI1121356T1 (es)
SK (1) SK285764B6 (es)
TR (1) TR200101808T2 (es)
TW (1) TW577884B (es)
UA (1) UA66888C2 (es)
WO (1) WO2000023441A1 (es)
ZA (1) ZA200103251B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2373855A1 (en) * 1999-05-12 2000-11-23 Solvay Pharmaceuticals B.V. Method of treating psychotic disorders
SK287018B6 (sk) 1999-08-23 2009-09-07 Solvay Pharmaceuticals B. V. Deriváty fenylpiperazínov, spôsob ich prípravy, farmaceutická kompozícia s ich obsahom a ich použitie
AR032711A1 (es) * 2001-02-21 2003-11-19 Solvay Pharm Bv Derivados de fenilpiperazina, un metodo para la preparacion de los mismos y una composicion farmaceutica que los contiene
AR032712A1 (es) * 2001-02-21 2003-11-19 Solvay Pharm Bv Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen
US7371769B2 (en) 2004-12-07 2008-05-13 Solvay Pharmaceuticals B.V. Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
US8101619B2 (en) 2004-12-08 2012-01-24 Solvay Pharmaceuticals B.V. Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
US9709700B2 (en) * 2005-04-06 2017-07-18 3M Innovative Properties Company Optical bodies including rough strippable boundary layers
ATE411161T1 (de) 2005-04-06 2008-10-15 3M Innovative Properties Co Optische körper mit rauen abziehbaren grenzschichten und asymmetrischen oberflächenstrukturen
US20060227421A1 (en) * 2005-04-06 2006-10-12 Stover Carl A Optical bodies including strippable boundary layers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4414113A1 (de) * 1994-04-22 1995-10-26 Merck Patent Gmbh 3-Indolylpiperidine
US5576321A (en) 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
ZA9711376B (en) 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives

Also Published As

Publication number Publication date
JP2002527515A (ja) 2002-08-27
HUP0104701A3 (en) 2003-01-28
IL142589A (en) 2007-10-31
NO320531B1 (no) 2005-12-19
KR100619464B1 (ko) 2006-09-05
NO20011892L (no) 2001-06-12
HUP0104701A2 (hu) 2002-04-29
DK1121356T3 (da) 2003-03-24
CA2346896A1 (en) 2000-04-27
BR9914582A (pt) 2001-07-03
JP4659984B2 (ja) 2011-03-30
ZA200103251B (en) 2002-07-22
PL347329A1 (en) 2002-03-25
SK5122001A3 (en) 2001-10-08
IL142589A0 (en) 2002-03-10
SI1121356T1 (en) 2003-04-30
PL195734B1 (pl) 2007-10-31
CA2346896C (en) 2008-12-09
TW577884B (en) 2004-03-01
WO2000023441A1 (en) 2000-04-27
CN1328553A (zh) 2001-12-26
NO20011892D0 (no) 2001-04-17
US6391896B1 (en) 2002-05-21
RU2222535C2 (ru) 2004-01-27
CN1140524C (zh) 2004-03-03
EP1121356B1 (en) 2003-01-08
HK1039333A1 (en) 2002-04-19
AR020773A1 (es) 2002-05-29
AU750811B2 (en) 2002-07-25
DZ2917A1 (fr) 2004-06-20
NZ511289A (en) 2003-01-31
DE69904849T2 (de) 2003-11-13
TR200101808T2 (tr) 2001-10-22
AU6474199A (en) 2000-05-08
KR20010080183A (ko) 2001-08-22
CZ20011353A3 (cs) 2001-09-12
SK285764B6 (sk) 2007-07-06
UA66888C2 (uk) 2004-06-15
EP1121356A1 (en) 2001-08-08
ATE230741T1 (de) 2003-01-15
DE69904849D1 (de) 2003-02-13

Similar Documents

Publication Publication Date Title
PE20060243A1 (es) Derivados de 4-amino insustituido-5-(4-urea-fenil)-pirrolotriazina
MY129772A (en) Crystal modification of a n-phenyl- 2 - pyrimidineamine derivative, processes for its manufacture and its use
FI941378A (fi) Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
FI943948A0 (fi) Heterosykliset hiilihappojohdannaiset
NO20032161L (no) Tetrahydrobenzazepinderivater for anvendelse som modulatorer av dopamine D3-reseptor (antipsykotiske midler)
DE69716226T2 (de) Difluoroprostaglandin-Derivate und ihre Anwendung
MY136685A (en) Thiazole derivatives for treating ppar related disorders
LU91417I2 (fr) "Maraviroc, optionnellement sous forme d'un sel pharmaceutiquement acceptable CELSENTRI"
DE60237145D1 (de) Chinazolinderivate
DE60012751D1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
NO20014925D0 (no) Farmasöytiske forbindelser
EP1533304A4 (en) AMIDE DERIVATIVE
TW200504085A (en) Derivatives of [2-(8,9-dioxo-2, 6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of use thereof
ES2188260T3 (es) 3-tetrahidropiridin-4-il-indoles para el tratamiento de trastornos pscoticos.
IL169184A0 (en) Aromatic compounds as anti-inflammatory, immunomdulatory and anti-proliferatory agents
ID24846A (id) Turunan-turunan bifenilamidina
EP1152004A4 (en) PHOSPHONIC ACID DERIVATIVES HAVING CARBOXYPEPTIDASE B INHIBITOR ACTIVITY
EP1034783A4 (en) AMIDE DERIVATIVES
MXPA02003952A (es) Derivados de imidazol como inhibidores de la fosfodieterasa vii.
AR052553A1 (es) Derivados de benzoil -tetrahidropiridina
ES2182775T3 (es) Derivados de ciclohexano 1,4-disustituidos para el tratamiento de la depresion.
AU6828898A (en) Phenylketiminooxybenzyl compounds, method for the production and use thereof
WO1999012535A8 (fr) Utilisation de derives de benzene sulfonamide pour obtenir un medicament destine au traitement de l'ejaculation retrograde ou de l'aspermie
MXPA04001001A (es) PRAMIPEXOL PARA EL TRATAMIENTO DEL TRASTORNO DE HIPERACTIVIDAD Y DeFICIT DE LA ATENCION.
EP1234576A4 (en) MEDICINE AGAINST EATING DISORDERS